Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Mead

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Antimicrobial Chemotherapy|April 9, 1998
In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvumX You, R F Schinazi, M J Arrowood, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimineD F Smee, J L Morris, J A Leonhardt, et al.
Parasite Immunology|April 9, 2005
Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO miceH N Ehigiator, P Romagnoli, K Borgelt, et al.
The Journal of Eukaryotic Microbiology|September 1, 1994
Isolation and partial characterization of Cryptosporidium sporozoite and oocyst wall recombinant proteinsJ R Mead, R M Lloyd, X You, et al.
The Journal of Eukaryotic Microbiology|January 29, 2000
Cryptosporidium andersoni n. sp. (Apicomplexa: Cryptosporiidae) from cattle, Bos taurusD S Lindsay, S J Upton, D S Owens, et al.
Infection and Immunity|May 1, 1994
Infection dynamics and clinical features of cryptosporidiosis in SCID miceJ R Mead, N Ilksoy, X You, et al.
Biotechnology Therapeutics|January 1, 1993
Effect of immunomodulators in the hu-PBL-SCID mouse modelJ R Mead, R A Burger, J D Morrey, et al.
Antiviral Research|March 1, 1992
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) miceJ D Morrey, J R Mead, R P Warren, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosisJ R Mead, X You, J E Pharr, et al.
The Journal of Eukaryotic Microbiology|September 1, 1996
Cloning and expression of sporozoite and oocyst Cryptosporidium parvum recombinant proteinsM T Bonafonte, R M Lloyd, K D Garmon, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|April 9, 1998
In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvumX You, R F Schinazi, M J Arrowood, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimineD F Smee, J L Morris, J A Leonhardt, et al.
Parasite Immunology|April 9, 2005
Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO miceH N Ehigiator, P Romagnoli, K Borgelt, et al.
The Journal of Eukaryotic Microbiology|September 1, 1994
Isolation and partial characterization of Cryptosporidium sporozoite and oocyst wall recombinant proteinsJ R Mead, R M Lloyd, X You, et al.
The Journal of Eukaryotic Microbiology|January 29, 2000
Cryptosporidium andersoni n. sp. (Apicomplexa: Cryptosporiidae) from cattle, Bos taurusD S Lindsay, S J Upton, D S Owens, et al.
Infection and Immunity|May 1, 1994
Infection dynamics and clinical features of cryptosporidiosis in SCID miceJ R Mead, N Ilksoy, X You, et al.
Biotechnology Therapeutics|January 1, 1993
Effect of immunomodulators in the hu-PBL-SCID mouse modelJ R Mead, R A Burger, J D Morrey, et al.
Antiviral Research|March 1, 1992
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) miceJ D Morrey, J R Mead, R P Warren, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosisJ R Mead, X You, J E Pharr, et al.
The Journal of Eukaryotic Microbiology|September 1, 1996
Cloning and expression of sporozoite and oocyst Cryptosporidium parvum recombinant proteinsM T Bonafonte, R M Lloyd, K D Garmon, et al.
Pageof 5